Tokushukai Medical Group

Clinical Research

Clinical research

Shonan Kamakura General Hospital Attached Clinical Research Center

Not a research for the research, but truly useful research for patients.

This center has established for consolidating each research steps in broader field, from basic research for intractable lesions including cancer and regeneration medicine, translational research to clinical research, into the one which this research center is to research and develop new diagnose and care method. Also Shonan Kamakura General Hospital is authorized as Research Organization on May 12, 2015 by Ministry of Education, Culture, Sports, Science and Technology. We will work out in pursuing of several field research activity from now on.

Interview at Medicine Research Institute.

Let me know a background of the establishment of Shonan Kamakura General Hospital Attached Clinical Research Center.

Needless to say, the research work at field is of course important, but the funds is also important for implementation of it. This fund consists with public one and private one. The Center is necessary to be as a recipient of these funds, and also to make usage of the funds fair and clean.

Let me know of the struggled points from the establishment to present.

It was a hectic work in making organization chart, articles of corporation and documents to submit to Ministry of Education, Culture, Sports, Science and Technology.

What is the most significant research theme which is currently working on at Shonan Kamakura General Hospital Attached Clinical Research Center?
  1. Evaluation in focus of manifestation of miRNA for early detection prior to disease generation or actualization, or of epigenetic modified mRNA rather than genome.
  2. Evaluation to make pathway to develop new anticancer drug by clarification of nuclear factor which controls the receptivity of anticancer drug.
  3. Various regeneration medicine, especially clinical application. We are moving towards the clinical application from the verification of the acute kidney failure model/chronic kidney disease model in the origin of the stem cells in the self or peripheral blood culture. Fat-derived stem cells breast reconstruction. Sooner, application research for cirrhosis of lever will start up.
  4. Clarification of AKI Onset factor by big data analysis: Clinical Epidemiology Research
  5. Disease-specific iPS cells foundation research with CiRA (collaboration with Kyoto University/Dr. Shinya Yamanaka)
Please let me know the thing which Research Center target for.

To conduct truly useful research for the patient, not research work for the Research. We are not a University so that it is important to research with looking ahead to 5 years, not 20 to 30 years later. They should certainly pay back to patients.

Research Department